Cholinesterase inhibitors, commonly used to treat dementia, could cause older adults to lose a “harmful” amount of weight, new research suggests.
University of California–San Francisco researchers compared data from a group of seniors. After 12 months, 29.3% of the patients on inhibitors had “significant” weight loss of 10 or more pounds, compared to 22.8% of patients on other medications.
Weight loss is a common problem in dementia patients, the researchers wrote in the August issue of the Journal of the American Geriatrics Society.
From the September 01, 2015 Issue of McKnight's Long-Term Care News
